CELBICON is a European project of the H2020 Program which consists of the development of new technologies for the transformation of atmospheric CO2 into industrial chemicals. These technologies will enable the cost-effective capture and purification of CO2 from the atmosphere through sorbents, with the electrochemical conversion of CO2 to products susceptible of being used as a carbon source in bacterial fermentation, followed by the application of bioreactors carrying out the Fermentation of the intermediate products of CO2 reduction (synthesis gas, water-soluble C1 molecules) and generate high added value products (bacterial bioplastics such as PHA, isoprene, lactic acid, methane, etc.).
A distinctive feature of the CELBICON project is the interaction and breakthroughs of key innovative technologies provided by business and academic partners to achieve unprecedented performance and efficiency results along the two following processing lines:
i) Line adapted to the production of PHA and pressurized methane through the intermediate electrochemical generation of pressurized synthesis gas followed by specific fermentation stages
(ii) Low pressure processing line focused on the production of value-added chemicals such as lactic acid through the fermentation of water-soluble intermediates derived from the transformation of atmospheric CO2.
The Polymer Biotechnology group participates in the platform that integrates PHA production by transforming the synthesis gas, which is generated previously from CO2. The key microorganism of the project is the bacterium Rhodospirillum rubrum optimized during the CELBICON process using synthetic biology and systems approaches.
CELBICON supports the EU objectives on the planned aspects of atmospheric CO2 reduction by the year 2020.
More info at: www.celbicon.org